Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population-specific bycatch risks in two vulnerable anadromous clupeids: Insights from otolith microchemistry.

Journal of fish biology·2026
Same author

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026
Same author

In vitro susceptibility testing of cefiderocol in different media of Mueller-Hinton agar.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026
Same author

In vitro activity of eravacycline against anaerobic bacteria isolated from clinically significant samples.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026
Same author

Microbiome-Metabolome Crosstalk as a Driver of COVID-19 Severity.

Medical sciences (Basel, Switzerland)·2026
Same author

Evaluation of Commercial Immunoassays for Rubella Virus IgG Detection in Low-Antibody Sera Using a Recombinant Immunoblot as a Reference Method.

Microorganisms·2026

Related Experiment Video

Updated: Mar 23, 2026

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

19.1K

Viruses Causing Hemorrhagic Fever. Safety Laboratory Procedures.

Fernando Cobo1

  • 1Microbiology Section (Biotechnology Area) and Tropical Medicine Unit.

The Open Virology Journal
|March 26, 2016
PubMed
Summary

Viral hemorrhagic fevers (VHFs) are severe, multisystem diseases caused by various viruses. Supportive care is primary treatment, with transmission occurring via animal contact or body fluids, especially when viral load is high.

Keywords:
Bleedinglaboratorylife-threateningprophylaxissafetytravelersviral hemorrhagic fever

More Related Videos

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.9K
Intracranial Injection of Adeno-associated Viral Vectors
08:47

Intracranial Injection of Adeno-associated Viral Vectors

Published on: November 17, 2010

49.1K

Related Experiment Videos

Last Updated: Mar 23, 2026

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

19.1K
Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.9K
Intracranial Injection of Adeno-associated Viral Vectors
08:47

Intracranial Injection of Adeno-associated Viral Vectors

Published on: November 17, 2010

49.1K

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Viral hemorrhagic fevers (VHFs) encompass a group of severe diseases caused by diverse viral families.
  • These infections can lead to a multisystem syndrome with significant morbidity and mortality.
  • Hemorrhagic manifestations are a common and severe outcome in many VHF cases.

Purpose of the Study:

  • To provide a comprehensive overview of viral hemorrhagic fevers.
  • To highlight the clinical presentation and outcomes of VHFs.
  • To discuss the transmission dynamics and management strategies for VHFs.

Main Methods:

  • Review of existing literature on viral hemorrhagic fevers.
  • Analysis of viral families associated with VHF.
  • Examination of transmission routes and risk factors.
  • Evaluation of current treatment and prevention strategies.

Main Results:

  • VHFs are caused by various viruses, often resulting in severe multisystem illness and hemorrhages.
  • Treatment primarily involves supportive therapy, with limited specific antiviral options.
  • Transmission occurs through animal vectors or human bodily fluids, with risk increasing with viral load.
  • No transmission risk exists during the incubation period.

Conclusions:

  • Effective management of VHFs requires understanding their diverse viral origins and clinical presentations.
  • Preventing transmission relies on safe handling of patients and specimens, especially by healthcare and laboratory workers.
  • Continued research into antiviral therapies and public health interventions is crucial for combating VHFs.